Prognostic value of Fluorine-18 3- deoxy-3-fluorothymidine ([18F]FLT) uptake in resectable liver metastases of colorectal cancer

Prognostic value of Fluorine-18 3- deoxy-3-fluorothymidine ([18F]FLT) uptake in resectable liver metastases of colorectal cancer - [18F]FLT liver metastases of colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36536

Enrollment

120

Registered

2010-07-05

Start date

2011-05-19

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bowel cancer colorectalcancer

Interventions

[18F]FLT PET(-CT).

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: *technically resectable liver metastases at the time of hepatic recurrence diagnosis *written informed consent

Exclusion criteria

Exclusion criteria: *claustrophobia prohibiting PET-scanning *systemic cancer therapy within 3 months prior to PET *largest liver metastasis

Design outcomes

Primary

Measure	Time frame
prognostic accuracy of [18F]FLT uptake in liver metastases with respect to patient outcomes (DFS),	—

Secondary

Measure	Time frame
prognostic accuracy of [18F]FLT uptake vs. existing prognostic indices with respect to patient outcomes (DFS).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)